Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients
- PMID: 27501215
- PMCID: PMC4958780
- DOI: 10.21037/jtd.2016.05.38
Detection of folate receptor-positive circulating tumor cells by ligand-targeted polymerase chain reaction in non-small cell lung cancer patients
Conflict of interest statement
Comment on
-
A preliminary study on the relationship between circulating tumor cells count and clinical features in patients with non-small cell lung cancer.Ann Transl Med. 2015 Dec;3(22):352. doi: 10.3978/j.issn.2305-5839.2015.11.18. Ann Transl Med. 2015. PMID: 26807407 Free PMC article.
Similar articles
-
Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.J Cancer. 2017 Jan 1;8(1):104-110. doi: 10.7150/jca.16856. eCollection 2017. J Cancer. 2017. PMID: 28123603 Free PMC article.
-
Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.J Thorac Oncol. 2015 Aug;10(8):1163-71. doi: 10.1097/JTO.0000000000000606. J Thorac Oncol. 2015. PMID: 26200270 Clinical Trial.
-
[Diagnostic Value of Folate Receptor-positive Circulating Tumor Cell in Lung Cancer: A Pilot Study].Zhongguo Fei Ai Za Zhi. 2016 Dec 20;19(12):813-820. doi: 10.3779/j.issn.1009-3419.2016.12.03. Zhongguo Fei Ai Za Zhi. 2016. PMID: 27978866 Free PMC article. Chinese.
-
Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801809. doi: 10.1177/1533033818801809. Technol Cancer Res Treat. 2018. PMID: 30244652 Free PMC article. Review.
-
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors.Ther Adv Med Oncol. 2015 Jul;7(4):206-18. doi: 10.1177/1758834015584763. Ther Adv Med Oncol. 2015. PMID: 26136852 Free PMC article. Review.
Cited by
-
Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer.Cell Oncol (Dordr). 2020 Feb;43(1):31-49. doi: 10.1007/s13402-019-00470-y. Epub 2019 Dec 11. Cell Oncol (Dordr). 2020. PMID: 31828552 Review.
-
The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.Clin Respir J. 2023 May;17(5):374-383. doi: 10.1111/crj.13601. Epub 2023 Mar 28. Clin Respir J. 2023. PMID: 36977421 Free PMC article.
-
Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer.Ann Transl Med. 2020 May;8(10):631. doi: 10.21037/atm-19-4680. Ann Transl Med. 2020. PMID: 32566568 Free PMC article.
-
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.Sci Rep. 2022 May 20;12(1):8555. doi: 10.1038/s41598-022-12118-3. Sci Rep. 2022. PMID: 35595733 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources